The program is still filling in: some talks have no title yet and more speakers will be added. We’ll add new sessions, the organizations presenting them and stand numbers once the floor plan is published.

Antibody and protein engineering at Festival of Biologics USA 2027

Apr 13–14, 2027 Boston, MA ~2k attendees Website

30 organizations at Festival of Biologics USA 2027 present work in antibody & protein engineering: 13 suppliers and service providers, 10 drug developers and 7 academic, government and non-profit bodies. Between them they bring 34 presentations to the program. Most represented: Pfizer (5 on the program), AbbVie (4 on the program), Bristol Myers Squibb (4 on the program). As of Oct 15, 2026.

All 126 organizations at Festival of Biologics USA 2027 →

Showing 1–14 of 30 organizations

Organization	Festival of Biologics USA 2027 Attendance
Pfizer New York, NY
pfizer.com Large pharma Develops and markets medicines and vaccines in oncology, inflammation and immunology, rare diseases and internal medicine.	Talk Tue Apr 13 12:00 Protein Engineering: title to be announced Talk Tue Apr 13 13:50 Vector construction for protein expression Bioprocessing Talk Tue Apr 13 14:30 Polysaccharide drug substance production: Optimization and scale-up of purification unit operations Bioprocessing Talk Tue Apr 13 15:10 Process characterization and purification of proteins Bioprocessing Also Presenting at the meeting, beyond the sessions above
AbbVie North Chicago, IL
abbvie.com Large pharma Develops and markets medicines in immunology, oncology, neuroscience and eye care, plus aesthetics.	Talk Tue Apr 13 11:40 Predictive frameworks to improve drug discovery AI & Data Talk Tue Apr 13 13:50 Biophysical characterisation and analytics of novel proteins Manufacturing Talk Wed Apr 14 11:40 Using AI ML to make Biobetters AI & Data Talk Wed Apr 14 14:00 Protein generation to support exploratory immunology Protein Engineering
Bristol Myers Squibb Princeton, NJ
bms.com Large pharma Develops and markets medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience, including cell therapies.	Talk Tue Apr 13 15:10 Downstream operations for protein purification Protein Engineering Talk Tue Apr 13 17:20 A Roadmap for Actionable AI usage AI & Data Talk Wed Apr 14 13:20 Analytical development of novel antibodies CMC Talk Wed Apr 14 15:00 Engineering Next-Generation T-Cell Engagers for Solid Tumors How adding a second activating signal to antibodies that link T cells to tumor cells could strengthen and prolong attacks on solid tumors.
AstraZeneca Cambridge, United Kingdom
astrazeneca.com Large pharma Develops and markets medicines in oncology, cardiovascular, renal, respiratory, immunology and rare diseases.	Talk Wed Apr 14 13:20 Advances in antibody-radioconjugate technology Armed Antibodies Talk Wed Apr 14 14:20 Advances in high throughput screening technologies for antibody production Protein Engineering Talk Wed Apr 14 14:40 Unnatural Precision: Site-specific conjugation for next generation ADCs How choosing where and how drugs attach to antibodies yields stabler antibody–drug conjugates and ones that carry two different drugs.
Merck Rahway, NJ
merck.com Large pharma Develops and markets medicines and vaccines, including the cancer immunotherapy Keytruda; known as MSD outside the US and Canada.	Talk Tue Apr 13 12:00 Continuous downstream processing advances Bioprocessing Talk Wed Apr 14 14:40 De novo designs for recombinant antibodies Protein Engineering Also Presenting at the meeting, beyond the sessions above
Genentech South San Francisco, CA
gene.com Large pharma Biotechnology company in the Roche Group developing medicines for cancer, immunology, neuroscience and other serious diseases.	Talk Tue Apr 13 15:10 Exploring costimulatory receptors CD28 and 4-1BB for cancer immunotherapy Antibodies for Immunotherapy Talk Wed Apr 14 13:20 Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Protein Engineering
Rondo Therapeutics
rondotx.com Biotech Clinical-stage developer of immune cell-engaging bispecific antibodies, including CD28 costimulatory bispecifics, for solid tumors.	Talk Tue Apr 13 13:50 Maximizing the power of bispecific therapies for treating solid tumors Antibodies for Immunotherapy Talk Tue Apr 13 14:30 Engineering CD28-based Costimulatory Bispecific Antibody Platform for the Treatment of Solid Tumors Protein Engineering
University of Pennsylvania Philadelphia, PA
	Talk Tue Apr 13 13:50 AI driven trial design and optimization AI & Data Talk Tue Apr 13 13:50 Engineering protein scaffolds for novel bispecific antibodies Protein Engineering
GeneFrontier
genefrontier.com Reagents & discovery toolsGold sponsor Sells PUREfrex, a cell-free protein expression system for hard-to-express proteins and high-throughput screening of therapeutic biologics.	Booth Exhibiting (no floor booth listed) Talk Tue Apr 13 14:50 Cell‑Free Antibody Engineering: Accelerating Discovery and Screening with PUREfrex® How a protein-making mix built from purified parts, with no living cells, quickly produces antibodies for library screening and AI-guided discovery.
Advanced Silicon Group Lowell, MA
advancedsilicongroup.com Instruments & analytics Makes silicon nanowire biosensors that measure protein levels, such as host cell proteins, in about 15 minutes.	Talk Wed Apr 14 11:40 From Hours to Minutes: Rapid Protein Measurement for Bioprocess Development and Manufacturing How a silicon sensor that measures specific proteins in under 15 minutes could catch problems sooner in biologic drug development and manufacturing.
Biodesign Institute, Arizona State University Tempe, AZ
	Talk Tue Apr 13 17:40 Enhanced Antibody Effector Function Through Glycoengineering mAbs
Johns Hopkins University Baltimore, MD
	Talk Tue Apr 13 16:40 Engineered cytokine/antibody fusion proteins as novel drugs for cancer immunotherapy Protein Engineering
La Jolla Institute for Immunology La Jolla, CA
	Talk Tue Apr 13 17:20 The Immune Epitope and Cancer Epitopes Databases as Tools to Support Development and Testing of Biologics mAbs
Mirador Therapeutics San Diego, CA
miradortx.com Biotech Develops precision medicines for immune-mediated inflammatory and fibrotic diseases.	Talk Tue Apr 13 11:40 Structural biology approaches to protein engineering Protein Engineering